ChartingTheGlobe

  1. Home
  2. United States
  3. Research
  4. R&D by business by area

Research & development by business enterprise, pharmaceutical industry in local currency in the United States

Line
Bar
Map
Table
The current research & development by business enterprise, pharmaceutical industry in local currency in the United States is 104,000.00 million, which has increased by 11,800.00 million (12.8%) since 2020.
Download image

Full screen

Close
Data currently not available for this time and region, try a different time period
Group by:
Value Equal sized Natural
Source:
Data availability:
Regions:
40
Date range: 1987 to 2022
Points:
779
Measure:
Current Local Currency
Similar regions to the United States Business R&D pharmaceutical in local currency
Japan
1,430,000.00M
+30,000.00M
(2022)
China
94,243.68M
+15,783.97M
(2021)
Germany
5,527.07M
+277.07M
(2021)
Mexico
1,000.24M
-69.99M
(2017)
More regions
More indicators for the United States
Government R&D in security as % of government support
40.85%
+0.74%
(2020)
Higher-education-finacing R&D financed by general university in local currency
0.00M
0.00M
(2022)
R&D financed by rest of the world in local currency
634,270.00M
+63,140.00M
(2022)
Government R&D financed by rest of the world in local currency
0.00M
0.00M
(2022)
Business R&D financed by rest of the world in local currency
619,470.00M
+62,450.00M
(2022)
Non-profit R&D growth rate
-6.04%
-2.16%
(2022)
More indicators
United States Business R&D pharmaceutical in local currency between 1987 and 2021
Period Business R&D pharmaceutical in local currency Change
2021 104,000.00M +11,800.00M
2020 92,200.00M +3,600.00M
2019 88,600.00M +13,000.00M
2018 75,600.00M +8,200.00M
2017 67,400.00M +2,600.00M
2016 64,800.00M +5,500.00M
2015 59,300.00M +2,700.00M
2014 56,600.00M +4,200.00M
2013 52,400.00M +4,300.00M
2012 48,100.00M +2,200.00M
2011 45,900.00M -3,500.00M
2010 49,400.00M +4,500.00M
2009 44,900.00M -3,200.00M
2008 48,100.00M +368.02M
2007 47,731.98M +8,831.98M
2006 38,900.00M +4,100.00M
2005 34,800.00M +3,300.00M
2004 31,500.00M +15,534.26M
2003 15,965.74M +1,764.85M
2002 14,200.89M +4,100.89M
2001 10,100.00M -2,700.00M
2000 12,800.00M +92.66M
1999 12,707.34M +40.46M
1998 12,666.88M +768.19M
1997 11,898.69M +2,128.69M
1996 9,770.00M -430.00M
1995 10,200.00M +570.00M
1994 9,630.00M +480.00M
1993 9,150.00M +1,210.00M
1992 7,940.00M +879.20M
1991 7,060.80M +773.45M
1990 6,287.35M +479.70M
1989 5,807.65M +901.45M
1988 4,906.20M +806.20M
1987 4,100.00M
×